VSVanessa Santos Silva

Vanessa Santos Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vanessa Santos Silva has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Standardization of a qPCR Assay for Seb and Stx1 Detection and Its Applications in Biodefense Systems

    by Victor Hugo Gonçalves Pinto, Samuel Dias da Silva, Beatriz de Paiva Mendes, Victor Hugo Giordano Dias, Marcos Dornelas Ribeiro, Caleb Guedes Miranda dos Santos, Vanessa dos Santos Silva, Tatiana Lúcia Santos Nogueira, Virginia Sara Grancieri Do Amaral

    Bacterial toxins, such as Staphylococcal Enterotoxin B (SEB) and Shiga Toxins (STX1, STX2), pose severe public health risks and significant biological threats, demanding rapid and precise qPCR detection. This study reports the initial stages of standardization for uniplex qPCR components, serving as a foundational step toward a future multiplex detection system. The annealing temperature was successfully optimized for the stx1, seb, and 16S rRNA targets, showing high consistency in Cq values and fluorescence intensities at 58.4 °C. The optimized primer ratios ensure maximum amplification efficiency while minimizing potential molecular competition. These optimized assays provide a robust foundation for the multiplex qPCR platform. Once fully validated, this protocol will enhance timely and effective responses, as well as improve preparedness and readiness within the Brazilian biodefense system.

  • Open Access

    Pulmonary Myeloid Cells in Mild Cases of COVID-19 Upregulate the Intracellular Fc Receptor TRIM21 and Transcribe Proteasome-Associated Molecules

    by Andrea Henriques-Pons, Maria Clicia S. Castro, Vanessa S. Silva, Maiana O. C. Costa, Helena S. I. L. Silva, Maria Emilia M. T. Walter, Anna Cristina C. Carvalho, Alba C. M. A. Melo, Kary Ocaña, Marcelo T. dos Santos, et al.

    Much remains to be understood about COVID-19, but the protective role of antibodies (Igs) is widely accepted in SARS-CoV-2 infection. Igs’ functions are mainly carried out by receptors that bind to their Fc portion (FcR), and less attention has been dedicated to the cytoplasmic members of this family. In this work, we used single-cell RNA sequencing (scRNA-seq) data to discern cell populations in bronchoalveolar lavage fluid obtained from healthy individuals and patients with mild or severe COVID-19. Then, we evaluated the transcription of neonatal FcR (FcRn, FCGRT gene) and tripartite motif-containing protein 21 (TRIM21) and its downstream signaling components. The TRIM21 pathway is vital for virus infections as it has a dual function, leading opsonized viruses to degradation by proteasomes and the activation of innate inflammatory anti-virus response. The transcriptional level of FCGRT showed no statistical differences in any cell population comparing the three groups of patients. On the other hand, TRIM21 transcription was significantly higher in myeloid cells collected from patients with mild COVID-19. When comparing mild with severe cases, there was no statistical difference in TRIM21 transcription in lung adaptive lymphoid cells and innate lymphoid cells (ILC). Yet, we analyzed the transcription of all downstream signaling molecules in myeloid and, as most cells expressed the receptor, in adaptive lymphoid cells. Moreover, ILCs from mild cases and all cell populations from severe cases were missing most downstream components of the pathway. We observed that members of the ubiquitin–proteasome system (UPS) and other components associated with TRIM21 proteasomal degradation were transcribed in mild cases. Despite the transcription of the danger sensors DDX58 and IFIH1, the transcriptional level of inflammatory IL1B and IL18 was generally very low, along with the NLRP3 danger sensor, members of the NF-κB pathway, and TNF. Therefore, our data suggest that TRIM21 may contribute to SARS-CoV-2 protection by reducing the viral load, while the inflammatory branch of the pathway would be silenced, leading to no pathogenic cytokine production.


  • Open Access

    Intracelular Fc Receptors in Lung Cells from COVID19 Patients

    by Andrea Henriques-Pons, Maria Clicia S. Castro, Vanessa Santos, Maiana O. C. Costa, Helena S. I. Silva, Maria Emília M. T. Walter, Anna Cristina C. Carvalho, Alba C.M.A. Melo, Kary Ocaña, Marcelo T Santos, et al.

    After global vaccination, there was a drastic reduction in COVID-19 severe cases. However, it is important to understand what physiopathological pathways played a role in patients protection during the pandemic’s first months. Much remains to be understood about the disease, but the protective role of antibodies (Ig) is widely accepted in SARS-CoV-2 infection. Ig functions are mainly carried out by receptors that bind to their Fc portion (FcR), and less attention has been dedicated to the cytoplasmic members of this family. In this work, we used single-cell RNA sequencing (scRNAseq) data to discern cell populations present in bronchoalveolar lavage fluid obtained from healthy individuals or patients with mild or severe COVID-19. Then, we evaluated the transcription of neonatal FcR (FcRn, FCGRT gene) and tripartite motif-containing protein 21 (TRIM21) and its downstream signaling components. The TRIM21 pathway is vital for virus infections as it has a dual function, leading opsonized viruses to degradation by proteasomes and the activation of innate inflammatory anti-virus response. Our findings yielded no supporting evidence to endorse the involvement of FcRn in protecting COVID-19 patients. On the other hand, TRIM21 and related members of the via, such as members of the ubiquitin-proteasome system (UPS), were consistently upregulated in innate and adaptive lymphoid and myeloid cells from mild cases. However, despite the transcription of the danger sensors DDX58 and IFIH1, the transcriptional level of inflammatory IL1B and IL18 was generally very low, along with the NLRP3 danger sensor, members of the NF-κB pathway, and TNF. Although there were much higher numbers of cells in the samples from patients with severe symptoms, most cells transcribed near-zero levels of TRIM21. Therefore, our data suggest that TRIM21 may contribute to SARS-CoV-2 protection by reducing the viral load, while not contributing to the inflammatory branch of the pathway and pathogenic cytokine strom.

  • Open Access

    CellHeap: A scRNA-seq workflow for large-scale bioinformatics data analysis

    by Maria Clicia S. Castro, Vanessa Santos Silva, Maiana Oliveira Costa, Helena S. I. L. Silva, Maria Emilia M. T. Walter, Alba C. M. A. Melo, Kary Ocaña, Marcelo Trindade dos Santos, Marisa Fabiana Nicolas, Anna Cristina C. Carvalho, et al.

    : Background: Several hundred terabytes of single-cell RNA-seq (scRNA-seq) data are available in public repositories. These data refer to various research projects, from microbial population cells to multiple tissues, involving patients with a myriad of diseases and comorbidities. An increase to several Petabytes of scRNA-seq data available in public repositories is a realistic prediction for coming years. Therefore, thoughtful analysis of these data requires large-scale computing infrastructures and software systems optimized for such platforms to generate correct and reliable biological knowledge. Results: This paper presents CellHeap, a flexible, portable, and robust platform for analyzing large scRNA-seq datasets, with quality control throughout the execution steps, and deployable on platforms that support large-scale data, such as supercomputers or clouds. As a case study, we designed a workflow to study particular modulations of Fc receptors, considering mild and severe cases of COVID-19. This workflow, deployed in the Brazilian Santos Dumont supercomputer, processed dozens of Terabytes of COVID-19 scRNA-seq raw data. Our results show that most of the workflow total execution time is spent in its initial phases and that there is great potential for a parallel solution to speed up scRNA-seq data analysis significantly. Thus, this workflow includes an efficient solution to use parallel computational resources, improving total execution time. Our case study showed increased Fc receptors transcription in macrophages of patients with severe COVID-19 symptoms, especially FCGR1A, FCGR2A, and FCGR3A. Furthermore, diverse molecules associated with their signaling pathways were upregulated in severe cases, possibly associated with the prominent inflammatory response observed. Conclusion: From the CellHeap platform, different workflows capable of analyzing large scRNA-seq datasets can be generated. Our case study, a workflow designed to study particular modulations of Fc receptors, considering mild and severe cases of COVID-19, deployed on the Brazilian supercomputer Santos Dumont, had a substantial reduction in total execution time when jobs are triggered simultaneously using the parallelization strategy described in this manuscript. Regarding biological results, our case study identified specific modulations comparing healthy individuals with COVID-19 patients with mild or severe symptoms, revealing an upregulation of several inflammatory pathways and an increase in the transcription of Fc receptors in severe cases.


  • Open Access

    Descrição da Primeira Fase do Workflow CellHeap para Análise Single-Cell RNA-seq

    by Gabriel P. T. Silva, Maria Clicia S. de Castro, Vanessa S. Silva, Fabrício A. B. Silva

    Este artigo descreve a etapa inicial do workflow CellHeap utilizado na análise dos dados de sequenciamento de células únicas (scRNA-seq). A Fase 1 deste consiste no download e validação dos dados de amostras a serem utilizados nas fases subsequentes. Ao fim, são descritos algumas melhorias planejadas para esta etapa.

  • Thiophenacetamide as a potential modulator to NF-κB: structure and dynamics study using in silico and molecular biology assays

    by Vanessa S. Silva, Fatima M. Vergara, Leonardo N. Seito, Deborah Antunes, Lucianna H. S. Santos, Maria G. Henriques, Ernesto R. Caffarena

    Nuclear factor kappa B (NF-κB) plays critical roles in the regulation of many pathophysiological processes, including inflammation and immune responses, cell growth and apoptosis. This DNA-binding protein receptor is considered an important molecular target to treat many diseases through host-directed therapy. In this line, several drugs containing thiophene cores have been extensively evaluated due to their ability to interfere on NF-κB translocation to the nucleus. In this work, essays using drug affinity responsive target stability (DARTS) revealed that the parent compound N-(Aryl)-2-thiophen-2-ylacetamide referred to as thiophenacetamide (TAA) specifically binds to the p65 subunit of the NF-κB. Since no experimental binding mode of TAA with p65 is available, we explored TAA within putative sites in silico to gain insights into its possible binding mode and behavior. The binding mode of TAA found in Site 1 formed hydrogen bonds with Lys37 and Asp125 on p65, important residues near DNA-binding region. Molecular dynamics simulations showed the stability of this mode of binding in contrast to the other also tested modes. Our results suggest that TAA binding could occur in regions close to residues responsible for DNA-binding, increasing NF-κB protein rigidity and affecting the association between DNA and NF-κB.